 "Zydus settles patent litigation for cholesterol lowering drug with Kowa")
Zydus Cadila has settled the patent litigation pertaining to cholesterol lowering drug Livalo (pitavastatin calcium) with Japan’s Kowa Company and Nissan Chemical.
“Cadila Healthcare Limited and its subsidiary Zydus Pharmaceuticals (USA) Inc have finalised an agreement with Kowa Company Ltd, Kowa Pharmaceuticals America Inc and Nissan Chemical Industries Ltd to settle all outstanding patent litigation related to Livalo (pitavastatin calcium) tablets,” said the company in a BSE filings yesterday.
Pitavastatin, a member of the blood cholesterol lowering medication class of statins, is indicated for hypercholesterolaemia (elevated cholesterol) and for the prevention of cardiovascular disease. Pitavastatin was discovered in Japan by Nissan Chemical Industries and developed further by Kowa Pharmaceuticals. The drug was approved for use in the US by the FDA in 2009 under the trade name Livalo.
Under the terms of the agreement, Kowa and Nissan have granted Zydus a license to market its generic version of Livalo beginning on May 2, 2023, or earlier under certain circumstances. Other terms of the settlement were not disclosed.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%